Larotrectinib Sulfate Bayer

Larotrectinib Sulfate Bayer · pharmadog

Patent cliff

source: FDA Orange Book

first barrier falls

Oct 21, 2029

~3.3 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (48)

May 16, 2037method-of-use (U-4123)US 11337967
May 16, 2037method-of-use (U-4123)US 11337967
May 16, 2037method-of-use (U-4123)US 11337967
May 16, 2037method-of-use (U-4124)US 11974998
May 16, 2037method-of-use (U-4124)US 11974998
May 16, 2037method-of-use (U-4124)US 11974998
Apr 4, 2037method-of-use (U-2473)US 10045991
Apr 4, 2037formulationUS 10137127
Apr 4, 2037formulationUS 10668072
Apr 4, 2037method-of-use (U-2471)US 11191766
Apr 4, 2037method-of-use (U-2470)US 11484535
Aug 15, 2036compositionUS 10799505
Aug 15, 2036compositionUS 10799505
Aug 15, 2036compositionUS 10799505
Nov 16, 2035compositionUS 10172861
Nov 16, 2035compositionUS 10172861
Nov 16, 2035compositionUS 10172861
Nov 16, 2035method-of-use (U-2470)US 10285993
Nov 16, 2035method-of-use (U-2470)US 10285993
Nov 16, 2035method-of-use (U-2987)US 10813936
Nov 16, 2035method-of-use (U-2987)US 10813936
Nov 16, 2035method-of-use (U-2471)US 9782414
Nov 16, 2035method-of-use (U-2475)US 9782414
Nov 16, 2035method-of-use (U-2475)US 9782414
Dec 23, 2029compositionUS 85132633.5y
Dec 23, 2029compositionUS 85132633.5y
Dec 23, 2029compositionUS 85132633.5y
Oct 21, 2029method-of-use (U-2472)US 100057833.3y
Oct 21, 2029method-of-use (U-2472)US 100057833.3y
Oct 21, 2029method-of-use (U-2472)US 100057833.3y
Oct 21, 2029method-of-use (U-2474)US 100470973.3y
Oct 21, 2029method-of-use (U-2474)US 100470973.3y
Oct 21, 2029method-of-use (U-2474)US 100470973.3y
Oct 21, 2029method-of-use (U-2470)US 107740853.3y
Oct 21, 2029method-of-use (U-2470)US 107740853.3y
Oct 21, 2029method-of-use (U-2470)US 107740853.3y
Oct 21, 2029method-of-use (U-2469)US 88656983.3y
Oct 21, 2029method-of-use (U-2469)US 88656983.3y
Oct 21, 2029method-of-use (U-2469)US 88656983.3y
Oct 21, 2029compositionUS 91270133.3y
Oct 21, 2029compositionUS 91270133.3y
Oct 21, 2029compositionUS 91270133.3y
Oct 21, 2029method-of-use (U-2470)US 94471043.3y
Oct 21, 2029method-of-use (U-2470)US 94471043.3y
Oct 21, 2029method-of-use (U-2470)US 94471043.3y
Oct 21, 2029method-of-use (U-2469)US 96767833.3y
Oct 21, 2029method-of-use (U-2469)US 96767833.3y
Oct 21, 2029method-of-use (U-2469)US 96767833.3y

larotrectinib sulfate

all catalysts(0)

News(0)

comments(0)

Report a data issue

Patent cliff

patents (48)